Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q3 FY2012
As of Sep 30, 2012
Q2 FY2012
As of Jun 30, 2012
Q1 FY2012
As of Mar 31, 2012
Q4 FY2011
As of Dec 31, 2011
Q3 FY2011
As of Sep 30, 2011
Q2 FY2011
As of Jun 30, 2011
Land
Parent Company
BIOMED REALTY, L.P.
Total land
Land Under Development
Parent Company
BIOMED REALTY, L.P.
Total land Under Development
Buildings and Improvements
Parent Company
BIOMED REALTY, L.P.
Total buildings and Improvements
Construction in Progress
Parent Company
BIOMED REALTY, L.P.
Total construction in Progress
Real Estate Investment Property, at Cost
Parent Company
BIOMED REALTY, L.P.
Total real Estate Investment Property, at Cost
Real Estate Investment Property, Accumulated Depreciation
Parent Company
BIOMED REALTY, L.P.
Total real Estate Investment Property, Accumulated Depreciation
Investments in real estate, net
Parent Company
BIOMED REALTY, L.P.
Total investments in real estate, net
Investments in unconsolidated partnerships
Parent Company
BIOMED REALTY, L.P.
Total investments in unconsolidated partnerships
Cash and cash equivalents
Accounts receivable, net
Accrued straight-line rents, net
Deferred leasing costs, net
Other assets
Total assets
Liabilities and Equity
Liabilities
Mortgage notes payable, net
Parent Company
BIOMED REALTY, L.P.
Exchangeable senior notes
Parent Company
BIOMED REALTY, L.P.
Unsecured senior notes, net
Unsecured Debt
Parent Company
BIOMED REALTY, L.P.
Unsecured senior term loans
Unsecured Debt
Parent Company
BIOMED REALTY, L.P.
Unsecured line of credit
Unsecured Line of Credit
Parent Company
BIOMED REALTY, L.P.
Accounts payable, accrued expenses and other liabilities
Total liabilities
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Preferred stock, $.01 par value, 15,000,000 shares authorized: 7.375% Series A cumulative redeemable preferred stock, no shares issued and outstanding at December 31, 2013; and 7,920,000 shares issued and outstanding at December 31, 2012, $198,000 liquidation preference ($25.00 per share)
Limited partners' capital, 5,398,224 and 5,405,474 units issued and outstanding at September 30, 2015 and December 31, 2014, respectively
General partner's capital, 203,527,787 and 197,442,432 units issued and outstanding at September 30, 2015 and December 31, 2014, respectively
Common stock, $.01 par value, 300,000,000 shares and 250,000,000 shares authorized, and 203,527,787 shares and 197,442,432 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively
Additional paid-in capital
Accumulated other comprehensive loss, net
Parent Company
BIOMED REALTY, L.P.
Total partners' capital
Dividends in excess of earnings
Total stockholders' equity
Noncontrolling interests / Noncontrolling interests deficit
Parent Company
BIOMED REALTY, L.P.
Total equity / capital
Total liabilities and equity / capital

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support